Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05377242 · ClinicalTrials.gov registry record · NA

Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI

A NA study of Gulf War Illness, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
390
Enrollment target
1
Study location

NCT05377242 is a NA study of Gulf War Illness that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 390 participants, above the 102-participant average among 14 other Gulf War Illness trials with a reported enrollment target (282% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05377242, a NA study of Gulf War Illness, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
390 participants
Enrollment target
1
Study location

Study Summary

This project's objective is to identify effective treatments for Gulf War Illness (GWI). The project tests three potential treatments: curcumin, stinging nettle, and resveratrol. The project uses a decentralized clinical trial (DCT) design in which individuals can participate from anywhere in the United States. Recruitment efforts will be designed to obtain a geographically and demographically diverse study sample.

Conditions Studied

Gulf War Illness

Interventions

  • DIETARY_SUPPLEMENT Curcumin
  • DIETARY_SUPPLEMENT Resveratrol
  • DIETARY_SUPPLEMENT Stinging Nettle

Study Locations (1)

Alabama

  • The University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2023-05-31
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05377242

The ClinicalTrials.gov registry entry for NCT05377242 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 102-participant average among 14 other Gulf War Illness trials with a reported enrollment target (282% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 3 interventions - of which Curcumin is the first listed.

NCT05377242 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05377242 about?

NCT05377242 is a clinical study titled "Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI". This project's objective is to identify effective treatments for Gulf War Illness (GWI). The project tests three potential treatments: curcumin, stinging nettle, and resveratrol. The project uses a decentralized clinical trial (DCT) design in which individuals can participate from anywhere in the Un...

What is the current status of trial NCT05377242?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 390 participants. The study started on 2023-05-31. Estimated completion is 2026-06-30.

What conditions does trial NCT05377242 study?

This clinical trial studies the following conditions: Gulf War Illness.

What interventions are being tested in trial NCT05377242?

The interventions under investigation include: Curcumin (DIETARY_SUPPLEMENT), Resveratrol (DIETARY_SUPPLEMENT), Stinging Nettle (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05377242?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05377242 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gulf War Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gulf War Illness

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.